NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Authors:
- Cheng Han NgCNCheng Han Ng
- Daniel Q. HuangDHDaniel Q. Huang
- Wen Hui LimWLWen Hui Lim
- Jieling XiaoJXJieling Xiao
- Clarissa FuCFClarissa Fu
- Rebecca Wenling ZengRZRebecca Wenling Zeng
- Yock Young DanYDYock Young Dan
- Nicholas SynNSNicholas Syn
Open Access
- 26 May 2023
- journal article
- letter
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (1) , 197-199.e3
Abstract
No abstract availableFunding Information
- National Institute of Environmental Health Sciences (5P42ES010337)
- National Center for Advancing Translational Sciences (5UL1TR001442)
- U.S. Department of War (W81XWH-18-2-0026)
- National Medical Research Council (MOH-000595-01)
- National Institute on Alcohol Abuse and Alcoholism (U01AA029019)
- Ministry of Health -Singapore
- National Heart, Lung, and Blood Institute (P01HL147835)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK120515, R01DK106419, R01DK121378, R01DK124318, U01DK061734, U01DK130190)
This publication has 10 references indexed in Scilit:
- Global epidemiology of cirrhosis — aetiology, trends and predictionsNature Reviews Gastroenterology & Hepatology, 2023
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerCell Metabolism, 2022
- Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysisThe Lancet Oncology, 2022
- UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 StudiesClinical Gastroenterology and Hepatology, 2022
- Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patientsHepatoBiliary Surgery and Nutrition, 2022
- Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized TherapyCellular and Molecular Gastroenterology and Hepatology, 2021
- Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019JAMA Network Open, 2020
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant CandidatesClinical Gastroenterology and Hepatology, 2019
- Survival analysis in the presence of competing risksAnnals of Translational Medicine, 2017
- Introduction to the Analysis of Survival Data in the Presence of Competing RisksCirculation, 2016